Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemia

Abreu, Cecilia; Moreno, Pilar; Palacios, Florencia; Borge, Mercedes; Landoni, Ana Inés; Gabús, Raúl; Dighiero, Guillermo; Morande, Pablo; Giordano, Mirta; Gamberale, Romina; Oppezzo, Pablo.
Leuk. Lymphoma ; 54(8): 1844-1848, 2013.
Artículo en Inglés | URUCAN | ID: bcc-4665

Documentos relacionados

  1. Methylation microarray-based detection of clinical copy-number aberrations in CLL benchmarked to standard FISH analysis.
  2. Investigation of fatty acid metabolism in chronic lymphocytic leukemia to guide clinical outcome and therapy.
  3. Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies.
  4. IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load.
  5. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
  6. NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts.
  7. Nucleosome repositioning in chronic lymphocytic leukemia.
  8. Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia.
  9. Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature.
  10. FISH-ing for answers: Can genomic arrays add to our understanding of disease biology in low-risk chronic lymphocytic leukaemia?